Pharma Reviews: Indian pharma grows at mere 1% in Sept quarter, recovery from GST disruption slow

Indian pharmaceutical market (IPM) continued to be sluggish even in September month as the recovery from the supply chain disruption caused due ...
Read more: Indian pharma grows at mere 1% in Sept quarter, recovery from GST disruption slow